As Europe's first virtual contract research organisation, we're on a mission to transform the world of clinical research. By digitalizing all stages of the study, and actively engaging patients as our design partners, we are able to create end-to-end experiences that reach previously excluded patient populations, and deliver superior outcomes for participants, investigators and sponsors alike.
Delivering superior clinical studies that put patients first is the heart of our business today. But what about the future? Two words: Personalized treatment. This exciting new approach for disease treatment uses a patient centric-approach to treatment development that takes into account a person's individual variability in environment and lifestyle, along with their genetic and physiological makeup. The result? A new era of medicine – one that delivers the right treatment, at the right time.
Why coordinate between multiple vendors to get one job done? With us, you don't have to. We deliver every aspect of your study from start to finish. Our services include:
Studies&Me has finalized a decentralized pilot study to test the data quality of blood sugar and behaviometric monitoring of type 2 diabetes patients in collaboration with Glostrup Pharmacy.
Studies&Me is conducting a decentralized clinical study in collaboration with Bispebjerg Hospital to investigate how genetics affect Atopic Dermatitis (AD).
Studies&Me is conducting a combined phase 1/2a interventional study for Coegin Pharma’s topical AVX001 in the treatment of precancerous skin lesions, Actinic Keratosis.
Virtual and hybrid-virtual trials are more than just a trend for strange and uncertain times. They present significant advantages over traditional brick-and-mortar trials, and unique attributes that enhance outcomes for sponsors, investigators and patients alike.
Less site visits
Increased study task compliance
Real world data
Reduced recall bias
Increased patient engagement
Faster data collection & processing
Enhanced visibility for investigators
Decreased patient burden